HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association

European Psychiatry

Volumn 27, Issue 5, 2012, Pages 372-376

  Voisey, J ^a   Swagell, C D ^a   Hughes, I P ^a   Lawford, B R ^a,b   Young, R M ^a   Morris, C P ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

COMT; Genotyping; Polymorphism; Schizophrenia; Sexual dimorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ALLELE; ARTICLE; AUSTRALIA; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HAPMAP PROJECT; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84862563433     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2010.08.004     Document Type: Article

References (38)

1. Abdolmaleky H.M., Cheng K.H., Faraone S.V., Wilcox M., Glatt S.J., Gao F., et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006, 15:3132-3145.
2. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004, 1:6.
3. Axelrod J., Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958, 233:702-705.
4. Bassett A.S., Chow E.W. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999, 46:882-891.
5. Bassett A.S., Hodgkinson K., Chow E.W., Correia S., Scutt L.E., Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998, 81:328-337.
6. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 1995, 57:289-300.
7. Bray N.J., Buckland P.R., Williams N.M., Williams H.J., Norton N., Owen M.J., et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003, 73:152-161.
8. Carter K.W., McCaskie P.A., Palmer L.J.J.L.I.N A java based linkage disequilibrium plotter. BMC Bioinformatics 2006, 7:60.
9. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821.
10. de Chaldee M., Laurent C., Thibaut F., Martinez M., Samolyk D., Petit M., et al. Linkage disequilibrium on the COMT gene in French schizophrenics and controls. Am J Med Genet 1999, 88:452-457.
11. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
12. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
13. Funke B., Malhotra A.K., Finn C.T., Plocik A.M., Lake S.L., Lencz T., et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 2005, 1:19.
14. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003, 160:469-476.
15. Goghari V.M., Sponheim S.R. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophr Res 2008, 103:186-191.
16. Gothelf D., Frisch A., Munitz H., Rockah R., Aviram A., Mozes T., et al. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am J Med Genet 1997, 72:455-461.
17. Graf W.D., Unis A.S., Yates C.M., Sulzbacher S., Dinulos M.B., Jack R.M., et al. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology 2001, 57:410-416.
18. Grossman M.H., Emanuel B.S., Budarf M.L. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. Genomics 1992, 12:822-825.
19. Gupta M., Chauhan C., Bhatnagar P., Gupta S., Grover S., Singh P.K., et al. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 2009, 10:277-291.
20. Hoenicka J, Garrido E, Martinez I, Ponce G, Aragues M, Rodriguez-Jimenez R, et al. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2009.
21. Hong J.P., Lee J.S., Chung S., Jung J., Yoo H.K., Chang S.M., et al. New functional single nucleotide polymorphism (Ala72Ser) in the COMT gene is associated with aggressive behavior in male schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:658-660.
22. Kremer I., Pinto M., Murad I., Muhaheed M., Bannoura I., Muller D.J., et al. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet B Neuropsychiatr Genet 2003, 119B:35-39.
23. Lachman H.M., Morrow B., Shprintzen R., Veit S., Parsia S.S., Faedda G., et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996, 67:468-472.
24. Lee S.G., Joo Y., Kim B., Chung S., Kim H.L., Lee I., et al. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 2005, 116:319-328.
25. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., et al. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet 1996, 6:131-133.
26. Meyer-Lindenberg A., Nichols T., Callicott J.H., Ding J., Kolachana B., Buckholtz J., et al. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 2006, 11:867-877. [797].
27. Munafo M.R., Bowes L., Clark T.G., Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005, 10:765-770.
28. Ohmori O., Shinkai T., Kojima H., Terao T., Suzuki T., Mita T., et al. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 1998, 243:109-112.
29. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., et al. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 2009, 110:140-148.
30. Ott J. Utility programs for analysis of genetic linkage, Program, HWE version 1.10. 1988, Columbia University, New York.
31. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994, 53:31-40.
32. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
33. Sazci A., Ergul E., Kucukali I., Kilic G., Kaya G., Kara I. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Res Mol Brain Res 2004, 132:51-56.
34. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002, 71:1296-1302.
35. Talkowski M.E., Kirov G., Bamne M., Georgieva L., Torres G., Mansour H., et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 2008, 17:747-758.
36. Wang Y., Hu Y., Fang Y., Zhang K., Yang H., Ma J., et al. Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia. Biol Psychiatry 2009, 65:1048-1054.
37. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999, 39:19-52.
38. Wonodi I., Stine O.C., Mitchell B.D., Buchanan R.W., Thaker G.K. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003, 120B:47-50.